STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Avadel Pharmaceuticals (Nasdaq: AVDL) has announced its upcoming participation in the 24th Annual Needham Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, April 8 at 1:30 p.m. ET.

Investors and interested parties can access a live webcast of the presentation through Avadel's Investor Relations website at investors.avadel.com. The recorded session will remain available on the website for 90 days following the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.09% News Effect

On the day this news was published, AVDL declined 4.09%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference on Tuesday, April 8 at 1:30 p.m. ET.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com
(212) 698-8696

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162


FAQ

When is Avadel Pharmaceuticals (AVDL) presenting at the Needham Healthcare Conference?

Avadel Pharmaceuticals will present on Tuesday, April 8 at 1:30 p.m. ET at the 24th Annual Needham Healthcare Conference.

How can investors watch Avadel's (AVDL) Needham Conference presentation?

Investors can watch the live webcast through Avadel's Investor Relations website at investors.avadel.com.

How long will Avadel's (AVDL) Needham Conference presentation be available for replay?

The recorded presentation will be available for 90 days following the conference on Avadel's Investor Relations website.

What type of presentation will AVDL give at the Needham Healthcare Conference?

Avadel's management team will participate in a fireside chat format presentation.
Avadel Pharmaceu

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Latest SEC Filings

AVDL Stock Data

2.09B
97.12M
4.89%
86.45%
10.8%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2